Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1983-05-09
1985-05-14
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544319, 544320, 544321, 514397, 514398, C07D23947, A61K 31505
Patent
active
045171882
ABSTRACT:
1-(4-Pyrimidinyloxy)-3-(hetarylalkylamino)-2-propanols are cardiovascular agents having a range of vasodilator and adrenergic beta-receptor blocking activities making these compounds useful anti-hypertensive agents. Preferred compounds bear a hydrazino or hydrazono substituent in the 2- position of the pyrimidine ring.
REFERENCES:
patent: 3337628 (1967-08-01), Crouther
patent: 4042586 (1977-08-01), Wasson
patent: 4139623 (1979-02-01), Jaeggi
patent: 4193995 (1980-03-01), Wasson
patent: 4321398 (1982-03-01), Matier
patent: 4324788 (1982-04-01), Dorigotti
Antonio et al., J. Med. Chemistry, 21, 123.
Lawson John E.
Matier William L.
Roth Herbert R.
Gerstl Robert
Mead Johnson & Company
Ryan Richard P.
Uloth Robert H.
LandOfFree
1-Pyrimidinyloxy-3-hetaryl-alkylamino-2-propanols does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-Pyrimidinyloxy-3-hetaryl-alkylamino-2-propanols, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-Pyrimidinyloxy-3-hetaryl-alkylamino-2-propanols will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-768056